| __timestamp | ACADIA Pharmaceuticals Inc. | Perrigo Company plc |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 152500000 |
| Thursday, January 1, 2015 | 73869000 | 187800000 |
| Friday, January 1, 2016 | 99284000 | 184000000 |
| Sunday, January 1, 2017 | 149189000 | 167700000 |
| Monday, January 1, 2018 | 187163000 | 218600000 |
| Tuesday, January 1, 2019 | 240385000 | 187400000 |
| Wednesday, January 1, 2020 | 319130000 | 177700000 |
| Friday, January 1, 2021 | 239415000 | 122000000 |
| Saturday, January 1, 2022 | 361575000 | 123100000 |
| Sunday, January 1, 2023 | 351619000 | 122500000 |
In pursuit of knowledge
In the ever-evolving landscape of pharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, ACADIA Pharmaceuticals Inc. has consistently outpaced Perrigo Company plc in R&D investment. From 2014 to 2023, ACADIA's R&D expenses surged by nearly 480%, peaking in 2022 with a remarkable 361 million dollars. In contrast, Perrigo's R&D spending remained relatively stable, with a modest increase of around 43% over the same period, reaching its highest in 2018.
This trend highlights ACADIA's aggressive pursuit of innovation, potentially positioning it as a leader in breakthrough therapies. Meanwhile, Perrigo's steady approach may reflect a focus on optimizing existing products. As the pharmaceutical industry continues to prioritize innovation, these spending patterns offer a glimpse into the strategic priorities of these two companies.
AbbVie Inc. vs Perrigo Company plc: Strategic Focus on R&D Spending
R&D Spending Showdown: Novartis AG vs ACADIA Pharmaceuticals Inc.
R&D Spending Showdown: Novartis AG vs Perrigo Company plc
Gilead Sciences, Inc. vs ACADIA Pharmaceuticals Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Regeneron Pharmaceuticals, Inc. and ACADIA Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and ACADIA Pharmaceuticals Inc.
Comparing Innovation Spending: Summit Therapeutics Inc. and Perrigo Company plc
Analyzing R&D Budgets: Ionis Pharmaceuticals, Inc. vs ACADIA Pharmaceuticals Inc.
Research and Development Expenses Breakdown: Rhythm Pharmaceuticals, Inc. vs ACADIA Pharmaceuticals Inc.
R&D Spending Showdown: Perrigo Company plc vs Amicus Therapeutics, Inc.
R&D Insights: How ACADIA Pharmaceuticals Inc. and Bausch Health Companies Inc. Allocate Funds
ACADIA Pharmaceuticals Inc. vs Galapagos NV: Strategic Focus on R&D Spending